Search results for "glycoproteins"

showing 10 items of 496 documents

TREM-1 ligand expression on platelets enhances neutrophil activation

2007

Abstract The triggering receptor expressed on myeloid cells 1 (TREM-1) plays an important role in the innate immune response related to severe infections and sepsis. Modulation of TREM-1–associated activation improves the outcome in rodent models for pneumonia and sepsis. However, the identity and occurrence of the natural TREM-1 ligands are so far unknown, impairing the further understanding of the biology of this receptor. Here, we report the presence of a ligand for TREM-1 on human platelets. Using a recombinant TREM-1 fusion protein, we demonstrate specific binding of TREM-1 to platelets. TREM-1–specific signals are required for the platelet-induced augmentation of polymorphonuclear leu…

Blood PlateletsLipopolysaccharidesIntegrinsNeutrophilsRecombinant Fusion ProteinsImmunologyIntegrinLigandsBiochemistryNeutrophil ActivationSepsisMiceImmunitySepsismedicineAnimalsHumansPlateletReceptors ImmunologicReceptorMembrane GlycoproteinsInnate immune systembiologyPneumoniaCell BiologyHematologymedicine.diseaseFusion proteinImmunity InnateTriggering Receptor Expressed on Myeloid Cells-1Disease Models AnimalGene Expression RegulationImmunologySelectinsbiology.proteinSelectinProtein BindingBlood
researchProduct

Identifying human platelet glycoproteins IIb and IIIa by capillary electrophoresis.

1998

Glanzmann thrombasthenia (GT) is an inherited hemorrhagic defect due to a failure of the platelet membrane glycoprotein (GP) IIb–IIIa complex. Capillary electrophoresis (CE) analysis of solubilized platelet membranes from normal individuals showed the presence of two peaks with a migration time of 27 and 29 min, respectively. An excellent run-to-run and day-to-day reproducibility of the technique (< 1% variation of the retention time) was documented. Using an automated Ferguson method, the apparent molecular masses were 100.0 kDa and 138.5 kDa, respectively. Immunoprecipitation with monoclonal antibodies anti-GP IIIa (B59.2.1) and anti-IIb (61.9.1.3) showed the two peaks as IIIa and IIb, re…

Blood PlateletsMaleClinical BiochemistryPlatelet Glycoprotein GPIIb-IIIa ComplexPlatelet membrane glycoproteinBiochemistryAnalytical ChemistryCapillary electrophoresisThrombastheniamedicineHumansPlateletChildPolyacrylamide gel electrophoresischemistry.chemical_classificationMembrane GlycoproteinsGlanzmann's thrombastheniaCell MembraneElectrophoresis Capillarymedicine.diseaseFlow CytometryMolecular biologyPrecipitin TestsPlatelet Glycoprotein GPIIb-IIIa ComplexchemistryGlycoproteinThrombastheniaElectrophoresis
researchProduct

High-throughput elucidation of thrombus formation reveals sources of platelet function variability

2019

In combination with microspotting, whole-blood microfluidics can provide high-throughput information on multiple platelet functions in thrombus formation. Based on assessment of the inter-and intra-subject variability in parameters of microspot-based thrombus formation, we aimed to determine the platelet factors contributing to this variation. Blood samples from 94 genotyped healthy subjects were analyzed for conventional platelet phenotyping: i.e. hematologic parameters, platelet glycoprotein (GP) expression levels and activation markers (24 parameters). Furthermore, platelets were activated by ADP, CRP-XL or TRAP. Parallel samples were investigated for whole-blood thrombus formation (6 mi…

Blood PlateletsPlatelet AggregationPlatelet Function TestsDISORDERSIntegrinPlatelet Membrane GlycoproteinsADHESIONPlatelet membrane glycoproteinArticleImmunophenotypingFlow cytometry03 medical and health sciences0302 clinical medicinePlatelet Biology & Its DisordersmedicineHumansPlateletPlatelet activationThrombuschemistry.chemical_classificationmedicine.diagnostic_testbiologyPlatelet CountThrombosisHematologyFlow CytometryPlatelet Activationmedicine.diseaseDIFFERENCEHigh-Throughput Screening AssaysCell biologychemistrybiology.proteinGPVIGlycoproteinBiomarkers030215 immunologyRESPONSESHaematologica-the Hematology Journal
researchProduct

Amelioration of spinal cord compressive injury by pharmacological preconditioning with erythropoietin and a nonerythropoietic erythropoietin derivati…

2006

Object Spinal cord injury (SCI) is a devastating clinical syndrome for which no truly efficacious therapy has yet been identified. In preclinical studies, erythropoietin (EPO) and its nonerythropoietic derivatives asialoEPO and carbamylated EPO have markedly improved functional outcome when administered after compressive SCI. However, an optimum treatment paradigm is currently unknown. Because the uninjured spinal cord expresses a high density of EPO receptor (EPOR) in the basal state, signaling through these existing receptors in advance of injury (pharmacological preconditioning) might confer neuroprotection and therefore be potentially useful in situations of anticipated damage. Methods…

Blotting WesternAsialoglycoproteinsPharmacologyNeuroprotectionCentral nervous system diseaseImmunoenzyme TechniquesRats Sprague-DawleySpinal cord compressionReceptors ErythropoietinMedicineAnimalsReceptorSpinal cord injuryErythropoietinSpinal Cord InjuriesAnalysis of Variancebusiness.industryGeneral MedicineSpinal cordmedicine.diseaseErythropoietin receptorRatsDisease Models Animalmedicine.anatomical_structureNeuroprotective AgentsErythropoietinImmunologybusinessmedicine.drugJournal of neurosurgery. Spine
researchProduct

Characterization of a disulphide-bound Pir-cell wall protein (Pir-CWP) ofYarrowia lipolytica

2003

In this work we have studied the disulphide-bound group of cell wall mannoproteins of Yarrowia lipolytica and Candida albicans. In the case of Y. lipolytica, SDS-PAGE analysis of the beta-mercaptoethanol-extracted material from the purified cell walls of the yeast form, showed the presence of a main polypeptide of 45 kDa and some minor bands in the 100-200 kDa range. This pattern of bands is similar to that obtained in identical extracts in Saccharomyces cerevisiae (Moukadiri et al., 1999), and besides, all these bands cross-react with an antibody raised against beta-mercaptoethanol-extracted material from the purified cell walls of S. cerevisiae, suggesting that the 45 kDa band could be th…

Blotting WesternMolecular Sequence DataSaccharomyces cerevisiaeYarrowiaBioengineeringCalcofluor-whiteApplied Microbiology and BiotechnologyBiochemistryHomology (biology)Fungal ProteinsCell wallCell WallCandida albicansGeneticsAmino Acid SequenceDisulfidesCloning MolecularDNA FungalPeptide sequenceMercaptoethanolFungal proteinMembrane GlycoproteinsBase SequencebiologyFungal geneticsMembrane ProteinsYarrowiabiology.organism_classificationBlotting SouthernMutagenesis InsertionalBiochemistrySequence AlignmentBiotechnologyYeast
researchProduct

Anti-GD3 antibodies are potent activators of human gamma/delta and alpha/beta positive T cells.

1995

The ganglioside GD3 has a variety of biological functions. These include stimulatory effects on proliferation, natural killer activity and cytokine production by freshly isolated peripheral T cells. In this study we have characterized anti-GD3 antibody (MoAb Z21) mediated effects on T cell clones. Our data indicate that alpha/beta TCR CD4+ and CD8+ as well as gamma/delta TCR positive T cells can be stimulated resulting in proliferation and cytokine production. This effect could be blocked by cyclosporin A and did not involve the LFA-3 or CD4 molecule. Apart from IFN-gamma and IL-2 production by T helper 1 and T helper 0 cells we have observed production of IL-4 and IL-10 by T helper 2 cells…

CD3 ComplexT cellReceptors Antigen T-Cell alpha-betaT-LymphocytesImmunologyBiologyLymphocyte ActivationInterleukin 21CD28 AntigensAntigens CDGangliosidesmedicineCytotoxic T cellHumansIL-2 receptorAntigen-presenting cellMembrane GlycoproteinsCD28Antibodies MonoclonalReceptors Antigen T-Cell gamma-deltaGeneral MedicineNatural killer T cellCD58 AntigensMolecular biologymedicine.anatomical_structureImmunologyCD4 AntigensCyclosporinelipids (amino acids peptides and proteins)CD8Scandinavian journal of immunology
researchProduct

Expression of Putative Fatty Acid Transporter Genes Are Regulated by Peroxisome Proliferator-activated Receptor α and γ Activators in a Tissue- and I…

1998

Regulation of gene expression of three putative long-chain fatty acid transport proteins, fatty acid translocase (FAT), mitochondrial aspartate aminotransferase (mAspAT), and fatty acid transport protein (FATP), by drugs that activate peroxisome proliferator-activated receptor (PPAR) alpha and gamma were studied using normal and obese mice and rat hepatoma cells. FAT mRNA was induced in liver and intestine of normal mice and in hepatoma cells to various extents only by PPARalpha-activating drugs. FATP mRNA was similarly induced in liver, but to a lesser extent in intestine. The induction time course in the liver was slower for FAT and FATP mRNA than that of an mRNA encoding a peroxisomal en…

CD36 AntigensMalemedicine.medical_specialtyAdipatesOrganic Anion TransportersReceptors Cytoplasmic and NuclearPeroxisome proliferator-activated receptorWhite adipose tissueBiologyMicrobodiesBiochemistryMiceLiver Neoplasms ExperimentalDiethylhexyl PhthalateInternal medicineBrown adipose tissueTumor Cells CulturedmedicineAnimalsClofibrateRNA MessengerMolecular BiologyDNA Primerschemistry.chemical_classificationMembrane GlycoproteinsBase SequenceFatty Acid Transport ProteinsFatty acidTroglitazoneCell BiologyPeroxisomeRatsPyrimidinesEndocrinologymedicine.anatomical_structureAdipose TissueGene Expression RegulationLiverchemistryPeroxisome proliferator-activated receptor alphaTranscription Factorsmedicine.drugJournal of Biological Chemistry
researchProduct

T-cell receptor transfer into human T cells with ecotropic retroviral vectors

2014

Adoptive T-cell transfer for cancer immunotherapy requires genetic modification of T cells with recombinant T-cell receptors (TCRs). Amphotropic retroviral vectors (RVs) used for TCR transduction for this purpose are considered safe in principle. Despite this, TCR-coding and packaging vectors could theoretically recombine to produce replication competent vectors (RCVs), and transduced T-cell preparations must be proven free of RCV. To eliminate the need for RCV testing, we transduced human T cells with ecotropic RVs so potential RCV would be non-infectious for human cells. We show that transfection of synthetic messenger RNA encoding murine cationic amino-acid transporter 1 (mCAT-1), the re…

CD4-Positive T-LymphocytesAdoptive cell transfermedicine.medical_treatmentGenetic enhancementGenetic VectorsReceptors Antigen T-CellCD8-Positive T-LymphocytesBiologyImmunotherapy AdoptiveJurkat cellsVesicular stomatitis Indiana virusCell LineJurkat CellsMiceTransduction (genetics)Viral Envelope ProteinsCancer immunotherapyTransduction GeneticGeneticsmedicineAnimalsHumansRNA MessengerMolecular BiologyCationic Amino Acid Transporter 1Membrane GlycoproteinsHEK 293 cellsT-cell receptorTransfectionAdoptive TransferVirologyElectroporationHEK293 CellsRetroviridaeLeukemia Virus Gibbon ApeMolecular MedicinePlasmidsGene Therapy
researchProduct

Allergen-induced IgE-dependent gut inflammation in a human PBMC-engrafted murine model of allergy.

2011

Background Humanized murine models comprise a new tool to analyze novel therapeutic strategies for allergic diseases of the intestine. Objective In this study we developed a human PBMC–engrafted murine model of allergen-driven gut inflammation and analyzed the underlying immunologic mechanisms. Methods Nonobese diabetic (NOD)– scid -γc −/− mice were injected intraperitoneally with human PBMCs from allergic donors together with the respective allergen or not. Three weeks later, mice were challenged with the allergen orally or rectally, and gut inflammation was monitored with a high-resolution video miniendoscopic system, as well as histologically. Results Using the aeroallergens birch or gra…

CD4-Positive T-LymphocytesAllergymedicine.medical_treatmentImmunologyHistamine AntagonistsAdministration OralInflammationNodMice SCIDPlatelet Membrane GlycoproteinsBiologymedicine.disease_causeImmunoglobulin ELymphocyte ActivationReceptors G-Protein-Coupledchemistry.chemical_compoundMiceAllergenimmune system diseasesAdministration RectalAntibody Specificityotorhinolaryngologic diseasesmedicineHypersensitivityImmunology and AllergyAnimalsHumansColitisMice KnockoutReceptors IgEAllergensImmunoglobulin Emedicine.diseaseDisease Models AnimalCytokinechemistryGastritisImmunologybiology.proteinLeukocytes MononuclearCytokinesPollenmedicine.symptomHistamineSpleenThe Journal of allergy and clinical immunology
researchProduct

Donor CD4 T cells convert mixed to full donor T-cell chimerism and replenish the CD52-positive T-cell pool after alemtuzumab-based T-cell-depleted al…

2009

Donor lymphocyte infusions (DLI) are used to resolve mixed T-cell chimerism (TCC) after allo-SCT despite a substantial risk of GVHD. We analyzed the impact of prophylactic CD8-depleted (CD8(depl)) DLI in 20 recipients of anti-CD52 alemtuzumab in vivo T-cell-depleted allografts with declining donor TCC after day +60. A total of 13 patients received CD8(depl) DLI and 7 patients did not. All but one of the DLI patients converted to complete donor T-cell chimeras, whereas only one non-DLI patient converted spontaneously. DLI induced transient acute GVHD in five and extensive chronic GVHD in two patients. These data suggest the use of CD8(depl) DLI as an effective treatment for mixed TCC, partic…

CD4-Positive T-LymphocytesAntibodies NeoplasmLymphocytemedicine.medical_treatmentHematopoietic stem cell transplantation*Lymphocyte DepletionT-Lymphocyte SubsetsAlemtuzumabddc:616Transplantation Chimera/*immunologyHematopoietic Stem Cell TransplantationAntibodies MonoclonalHematologyMiddle Agedmedicine.anatomical_structureCD52 AntigenLymphocyte TransfusionAlemtuzumabmedicine.drug*GlycoproteinsAdultCD52T cellAntibodies Monoclonal/therapeutic useAntineoplastic AgentsCD4-Positive T-Lymphocytes/*transplantationAntibodies Monoclonal HumanizedLymphocyte DepletionAntigens CDAntigens NeoplasmmedicineAntibodies Neoplasm/therapeutic useHumans*Peripheral Blood Stem Cell TransplantationAgedCell ProliferationGlycoproteinsLymphocyte Transfusion/*methodsTransplantationPeripheral Blood Stem Cell TransplantationTransplantation Chimerabusiness.industryAntineoplastic Agents/therapeutic usemedicine.diseaseTransplantationGraft-versus-host disease*Antigens NeoplasmImmunology*Antigens CDbusinessCD8Bone marrow transplantation
researchProduct